First Header Logo Second Header Logo

Susan Melin

Concepts (114)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Teaching
1
2018
55
0.740
Why?
Evidence-Based Medicine
1
2018
201
0.680
Why?
Neoplasms
2
2018
676
0.660
Why?
Internship and Residency
1
2018
271
0.580
Why?
Breast Neoplasms
5
2017
730
0.440
Why?
Anthracyclines
4
2017
54
0.390
Why?
Antineoplastic Agents
3
2017
600
0.340
Why?
Thalidomide
1
2007
35
0.340
Why?
Scalp
2
2017
34
0.330
Why?
Alopecia
2
2017
26
0.330
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2017
443
0.290
Why?
Esophageal Neoplasms
3
2006
34
0.230
Why?
Taxoids
3
2017
48
0.200
Why?
Neoadjuvant Therapy
4
2017
59
0.190
Why?
Interprofessional Relations
1
2018
54
0.190
Why?
Hypothermia, Induced
1
2017
17
0.170
Why?
Attitude of Health Personnel
1
2018
165
0.170
Why?
Clinical Competence
1
2018
302
0.150
Why?
Fluorodeoxyglucose F18
2
2006
53
0.150
Why?
Radiopharmaceuticals
2
2006
84
0.150
Why?
Head and Neck Neoplasms
1
2017
115
0.150
Why?
Adult
12
2017
8719
0.140
Why?
Adenocarcinoma
4
2006
303
0.140
Why?
Humans
16
2018
29286
0.140
Why?
Skin Neoplasms
1
2017
230
0.140
Why?
Aged, 80 and over
8
2013
3924
0.140
Why?
Aged
12
2017
10068
0.140
Why?
Middle Aged
12
2017
11572
0.130
Why?
Dose-Response Relationship, Drug
4
2013
674
0.130
Why?
Quality of Life
2
2017
869
0.130
Why?
Leukemia
1
2013
44
0.130
Why?
Lymphoma
1
2013
43
0.130
Why?
Antibiotics, Antineoplastic
1
2013
70
0.130
Why?
Female
14
2017
18970
0.120
Why?
Pancreatic Neoplasms
2
2005
130
0.120
Why?
Colorectal Neoplasms
2
2007
232
0.120
Why?
Chemotherapy, Adjuvant
3
2017
184
0.110
Why?
Neoplasm Recurrence, Local
1
2013
343
0.100
Why?
Aorta
1
2009
116
0.100
Why?
Treatment Outcome
4
2013
3173
0.090
Why?
European Continental Ancestry Group
1
2013
1359
0.090
Why?
Antineoplastic Agents, Phytogenic
1
2007
44
0.080
Why?
Paclitaxel
1
2007
82
0.080
Why?
Administration, Oral
1
2007
180
0.080
Why?
Lymphatic Metastasis
3
2014
160
0.080
Why?
Camptothecin
2
2005
50
0.080
Why?
Deoxycytidine
2
2005
69
0.080
Why?
Cardiovascular Diseases
1
2013
1102
0.070
Why?
Prospective Studies
4
2017
2036
0.070
Why?
Male
9
2013
18658
0.070
Why?
Survival Rate
4
2013
857
0.070
Why?
African Americans
1
2013
1647
0.070
Why?
Combined Modality Therapy
4
2006
565
0.060
Why?
Fluorouracil
1
2002
84
0.060
Why?
Disease-Free Survival
2
2013
309
0.050
Why?
Predictive Value of Tests
2
2013
818
0.040
Why?
Medical Illustration
1
2017
7
0.040
Why?
Cryotherapy
1
2017
15
0.040
Why?
Photography
1
2017
38
0.040
Why?
Headache
1
2017
82
0.040
Why?
Risk
1
2017
312
0.040
Why?
Radiotherapy Dosage
2
2006
107
0.040
Why?
Young Adult
2
2013
2427
0.040
Why?
Retrospective Studies
2
2014
2980
0.040
Why?
Carcinoma, Squamous Cell
2
2006
152
0.040
Why?
Receptor, erbB-2
1
2014
57
0.030
Why?
Receptors, Estrogen
1
2014
108
0.030
Why?
Ergocalciferols
1
2013
3
0.030
Why?
Troponin I
1
2013
17
0.030
Why?
Hypercalcemia
1
2013
8
0.030
Why?
Natriuretic Peptide, Brain
1
2013
63
0.030
Why?
Mastectomy
1
2013
64
0.030
Why?
Feasibility Studies
1
2013
261
0.030
Why?
Neoplasm Metastasis
1
2013
211
0.030
Why?
Ventricular Function, Left
1
2013
259
0.030
Why?
Age Factors
1
2014
1185
0.030
Why?
Stroke Volume
1
2013
325
0.030
Why?
Half-Life
1
2007
24
0.020
Why?
Blood Cell Count
1
2007
26
0.020
Why?
Area Under Curve
1
2007
94
0.020
Why?
Time Factors
1
2013
2105
0.020
Why?
Follow-Up Studies
1
2013
2198
0.020
Why?
Treatment Failure
1
2007
165
0.020
Why?
Case-Control Studies
1
2009
938
0.020
Why?
Magnetic Resonance Imaging
1
2013
1240
0.020
Why?
Esophagectomy
1
2006
16
0.020
Why?
Survival
1
2006
13
0.020
Why?
Tomography, Emission-Computed
1
2005
26
0.020
Why?
Thrombocytopenia
1
2005
34
0.020
Why?
Vomiting
1
2005
35
0.020
Why?
Radiotherapy, Adjuvant
1
2005
72
0.020
Why?
Gastrointestinal Diseases
1
2005
42
0.020
Why?
Diarrhea
1
2005
58
0.020
Why?
Fatigue
1
2005
76
0.020
Why?
Nausea
1
2005
68
0.020
Why?
Adolescent
1
2013
3191
0.020
Why?
Positron-Emission Tomography
1
2006
171
0.020
Why?
Risk Factors
1
2013
3731
0.020
Why?
Drug Administration Schedule
1
2005
275
0.020
Why?
Neoplasm Staging
1
2005
469
0.020
Why?
Multivariate Analysis
1
2005
703
0.020
Why?
Reproducibility of Results
1
2006
724
0.020
Why?
Disease Progression
1
2005
603
0.020
Why?
Drug Administration Routes
1
2002
12
0.020
Why?
Leucovorin
1
2002
24
0.020
Why?
Ethnic Groups
1
2006
545
0.020
Why?
Neutropenia
1
2002
30
0.020
Why?
Abdominal Neoplasms
1
2002
15
0.020
Why?
Drug Synergism
1
2002
68
0.020
Why?
Methotrexate
1
2002
65
0.010
Why?
Lymph Nodes
1
2002
92
0.010
Why?
Cohort Studies
1
2005
1764
0.010
Why?
Liver Neoplasms
1
2002
174
0.010
Why?
Lung Neoplasms
1
2002
388
0.010
Why?
Melin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (114)
Explore
_
Co-Authors (17)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_